Trial Profile
The phase I study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Fluorouracil (Primary) ; Nedaplatin (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- 19 Feb 2011 New trial record